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monomethyl arginine), a specific inhibitor of NO synthesis, was studied on
the coronary vascular effects of SP The specificity of L-NMMA was tested us-
ing the endothelium-independent dilator, sodium nitroprusside (SNP). Fifteen
pts with angiographically normal epicardial coronary arteries «20% steno-
sis) had intracoronary SP (5,10,20 pmol/min) and SNP (40 ~g/min) given be-
fore and after L-NMMA (64 ~mollmin). Coronary blood flow was measured
by Doppler flow wire and diameter by quantitative angiography.
Results: At baseline, a peak 17 ± 18% (mean ± SO, P < 0.01) increase
in distal coronary artery diameter, and a 20 ± 18% (p < 0.01) decrease in
coronary vascular resistance (CVR) indicated epicardial and microvascular
dilation with SP At rest, L-NMMA caused a 22 ± 27% increase in CVR and
a 13 ± 13% reduction in CA diameter, indicating tonic basal release of NO
from coronary epicardial and microvessels. L-NMMA also suppressed the
dilatory effects of SP (p < 0.01): after L-NMMA, SP produced an insignifi-
cant change in diameter 1+1 ± 15%) and CVR was 42% higher compared to
control. SNP produced a 19 ± 17% increase in epicardial CA diameter and
a 55 ± 20% reduction in CVR at baseline that was not significantly altered
by L-NMMA, suggesting that the effects of L-NMMA on the responses to SP
are specifically due to inhibition of NO production.
Conclusion: Human coronary epicardial and microvascular dilation with SP
is due, at least partly, to release of NO. Disease-induced differences in re-
sponses to endothelium-dependent dilators may be explained by a variation
in the extent to which specific receptors on the endothelial surface are af-
fected by pathologic conditions.
Endothelin (ET) is an endothelium-derived vasoactive peptide, its possible
contribution to myocardial ischemia and infarction is not yet well understood.
Aim of the study was to elucidate whether a brief period of myocardial
ischemia (CI) not leading to myocardial infarction may increase plasma ET
levels and to determine the kinetics of a possible ET release.
A coronary sinus lactate study with incremental atrial pacing was per-
formed in 16 patients (pts) with obstructive coronary artery multivessel dis-
ease (CAD). A Zucker-catheter was positioned in the distal coronary sinus
for incremental atrial pacing (100-160 bpm) and lactate sampling, ET was
measured by a radio-immuno-assay 1100% ET-1, 52% ET-2, 96% ET-3, 7%
Big-ET, Nichols Institute). ET, cardiac troponin-T (TnT, Boehringer Mannheim)
and creatine phosphokinase (CPK) samples were withdrawn from the coro-
nary sinus (CS) and a peripheral vein (PV) before and at time 1, 5, 10,30, 45
min, 1, 2, 3, 6 h after pacing. Significant ST depressions in the 12-lead ECG
after pacing was a further criterion for CI. A comparison to the results of a
control group (CG, n = 13) without heart disease and statistical analysis was
done.
Results: In CAD pacing stress induced a CI in all pts (duration 6.1 ± 1.2
min). The mean cardiac lactate production was 143.9 ± 19.3% compared
with the arterial lactate concentration, all pts suffered from typical angina
pectoris, significant ST depressions of 0.32 ± 0.11 mV were found in 14/16
pts. All pts developed pathological elevated ET concentration, whereas the
levels in the CG were within the limits of normal (p < 0.003). The mean ET
concentrations increased from 5.0 pg/ml in CS and PV before pacing to 10.9
pg/ml in CS and 8.9 pg/ml in PV at 1 min after the end of pacing. The concen-
trations further remained elevated within 1 h after pacing with higher levels
in CS than in PV due to a persisting cardiac release of ET, ET concentrations
dropped to the limits of normal (2.3-5.3 pg/ml) after 1 h with identical levels
in CS and PV In both groups TnT and CPK were not elevated, no signs of CI
were detected in the CG
Conclusions: A short lasting severe myocardial ischemia without myocar-
dial infarction was followed by a significant ET release for 1 h reaching 218%
of the base line concentration in CS and 178% in PV respectively. The higher
ET levels in CS compared to PV indicate, that the ET release is of cardiac
origin.
Contribution of Nitric Oxide to Post-Ischemic
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Dysfunction
Nader Dakak, Syed S, Husain, Neil P. Andrews, David Mulcahy, Julio A. Panza,
Arshed A. Quyyumi. National Institutes of Health, Bethesda, MD
Post-ischemic vasodilation during reactive hyperemia is believed to be pri-
marily due to accumulation of ischemic metabolites. To investigate the con-
tribution of nitric oxide (NOI release from vascular endothelium to reactive
hyperemia in humans, we studied the effect of inhibition of NO synthesis
using L-NG monomethyl arginine (L-NMMA) in 40 pts, 22 with, and 18 with-
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High dose NO (16 ~mol/min) caused an increase in endocardial and to-
tal myocardial blood flow which was similar to that produced by acetyl-
choline.Conclusions: Nitric oxide causes dose dependent increases in my-
ocardial blood flow and the endocardial to epicardial blood flow ratio. High
dose endoluminal NO infusion causes changes in myocardial blood flow and
transmural myocardial perfusion which are equivalent to that caused byen-
dothelial derived NO, Moreover, whether administered exogenously or re-
leased endogenously, NO is a preferential sub-endocardial vasodilator.
The effects of nitric oxide (NO) on myocardial blood flow (MBFI have been
studied previously by observing responses to agents that stimulate or block
endogenous NO release. To study the direct in vivo effects of endoluminally
administered NO on transmural myocardial perfusion, we studied 4 anes-
thetized dogs using a new method for intracoronary NO administration. NO
gas was bubbled through deoxygenated saline to achieve the saturation con-
stant (2-3 mM), During ventricular pacing at 100 beats/min, the solution was
infused into the left main coronary artery at doses of 0.2 and 16 ~mol/min,
Transmural myocardial perfusion and coronary blood flow were measured
with radioactive microspheres after 2 minutes of infusion. Changes in MFB
(ml/gm/min) induced from continuous NO infusion were compared to en-
dothelially mediated NO release induced by intracoronary administration of
acetylcholine (Ach 2,0 ~mollmin) and non-NO mediated vasodilitation by in-
tracoronary adenosine (AD 1.2 ~mol/min).
Results:
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Paradoxical vasoconstriction of stenotic coronary arteries has been reported
during dynamic exercise (Ex) in patients with coronary artery disease (CADI.
Thus, 19 patients with CAD were studied at rest (R), during 2 levels of supine
bicycle Ex, and after 1,6 mg sUblingual nitroglycerin. The cross-sectional area
(CSAI of a normal and a stenotic vessel was determined by biplane quanti-
tative coronary arteriography. Seven patients were given 2 mg intracoronary
phentolamine (PHE) prior to Ex, whereas 12 patients without pretreatment
served as controls (C). Workload was 81 ± 34 watts in C and 92 ± 18 watts
in PHE Ins). Mean aortic pressure during Ex was 107 ± 19 mmHg in C and
123 ± 16 mmHg in PHE (ns).
Percent changes in CSA were as follows:
60,-------------,------------,
Conclusions: Exercise-induced vasoconstriction of stenotic coronary arter-
ies is prevented by intracoronary administration of phentolamine. This obser-
vation suggests that exercise-induced vasoconstriction is mediated, at least
in part, by alpha-adrenergic mechanisms.
Alpha-Adrenergic Mechanisms in Exercise-
induced Vasoconstriction of Stenotic Coronary
Arteries
Substance P (SP) may be a more useful endothelium-dependent vasodila-
tor in studying coronary vascular function in atherosclerosis, because unlike
acetylcholine (ACH). SP has no direct smooth muscle constricting effects.
Because dilation has been reported with SP in pts with constriction with
ACH, we investigated whether SP causes dilation by releasing nitric oxide
(NO) from the human coronary vasculature. The effect of L-NMMA (L-NG
Investigation of Nitric Oxide Release from Human
Coronary Arteries with Substance P
David Mulcahy, Syed S. Husain, Neil P. Andrews, Julio A. Panza, Gregory
B. Johnson, Richard O. Cannon III. Arshed A. Quyyumi. National Institutes of Health,
Bethesda, MD
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Hemodynamics/Shock/Assist Devices
Parameter Cathete. Bel. ECC AfterECC 24 h 48 h
Call/min) 3.66 3.77 679 6.49 580
CIIl/min/m2) 187 2.02 3.79 3.46 3.10
CVPlmmHg) 833 8.26 3.65 456 4.76
PAPlmmH9) 3817 31.60 2060 22.60 25.00
PCW(mmHg) 2508 21.00 11.10 11.70 13.10
PVR (dyn.sec.cm-5 ) 60529 461 212 257 291
SVR (dyn.sec.cm-5 ) 3285 3552 1771 1694 1897
Patients with primary dilated cardiomyopathy particularly at the terminal
stage represent a special clinical problem because of refractoriness to medi-
cal treatment. The influence of mitral and tricuspid regurgitation to the hemo-
dynamic parameters is very important. In our institution the correction of mi-
tral and tricuspid insufficiency was performed in 24 patients 15 females and
19 males) with the mean age of 48 years. Reconstruction of the mitral annu-
lus was carried out by the application of Carpentier's ring and by the method
of Prof. Radovanovic in 9 and 15 patients, respectively.
The analysis of hemodynamic parameters was made in the period prior to
the surgical intervention (cardiac catheterization, before ECC) and after the
correction (after ECC. 24 and 48 hours from ECCj. The results are presented
in the table:
Postoperative mortality 130 days) was 0.0%. According to our results, sig-
nificant hemodynamic and clinical improvement in patients with severe heart
failure was attained by the correction of mitral and tricuspid insufficiency.
It may serve as a bridge to heart transplantation. Early correction of mitro-
tricuspid regurgitation slows down progression of myocardial insufficienr::y.
To determine whether one single cross-section obtained with intracoronary
ultrasound (ICUS) at the most stenotic site is representative for the ultimate
outcome following balloon angioplasty, 25 coronary artery specimens were
studied in vitro using a displacement sensing device. Corresponding ultra-
sound cross-sections (n = 250) were compared with their histologic coun-
terpart.
Qua/itative: Prior to intervention the sensitivity and specificity of eccen-
tric/concentric and soft/hard was high (:::94%); the specificity of lipid was
high (81 %), whereas its sensitivity was low (31 %). Following intervention
the specificity of morphologic features present was higher than the sensi-
tivity: dissection 100% vs 60%; plaque rupture 93% vs 16%; and internal
elastic lamina rupture 94% vs 54%. Similar data were obtained for all cross-
sections and at the most stenotic site. The incidence of pathologic changes
at the most stenotic site was higher compared to the overall result. Consid-
ering all cross-sections evaluated. concentric lesions were more frequently
associated with a dissection and plaque rupture than eccentric lesions; no
such relation was evidenced at the most stenotic site.
Quantitative: As result of balloon angioplasty ICUS imaging revealed an in-
crease in free lumen area (FLA) and media-bounded area (MBA), whereas
plaque area (PLA) reduced slightly. Large differences were encountered
when mean values were compared with values obtained at the most stenotic
site: FLA increase 30% vs 60% and MBA increase 12% vs 20%. No differ-
ences were found in mean PLA reduction and PLA reduction at the most
stenotic site (5% vs 8%).
Conclusion: This is the first in vitro study that systematically examined
coronary arteries with ICUS before and after balloon angioplasty. Comparing
the overall data obtained within the dilated specimen to the most stenotic
site it was found that similar data were obtained for sensitivity and specificity.
The pathologic and quantitative changes seen at the most stenotic site fol-
lowing intervention were more outspoken compared to the overall data.
Elma J. Gussenhoven, Aad van der Lugt, Salem H.K. The, Wenguang Li,
Theo Stijnen, Frans C. van Egmond, Jeroen van Essen, Hero van Urk,
Nicolaas Bom. University Hospital Rotterdam-Dijkzigt. Erasmus University Rotterdam
and the Interuniversity Cardiology Institute, The Netherlands
Correction of Mitral and Tricuspid Regurgitation
Improves Hemodynamic and Clinical Status in
the Patients with Primary Dilated Cardiomyopathy
N. Radovanovic, F. Vuk, Lj. Petrovic, J. Lavac, M. Kovac, M. Popov, B. Mihajlovic,
Z. Potie. University Clinic of Cardiovascular Surgery Novi Sad, Yugoslavia
Balloon Angioplasty Evaluated In Vitro by
Intracoronary Ultrasound: A Validation with
Histology
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We present five patients (4 females, 1 male, age range 62-79 yrs) with se-
vere hypotension aggressively treated and who had persistent shock. The
clinical setting included 2 pts following SVT, 2 pts postoperatively, and 1 pt
with hemorrhagic shock. The initial evaluation suggested aortic dissection,
cardiac tamponade, acute mitral regurgitation, cardiac contusion or cardio-
genic shock. A transthoracic echo was performed and was nondiagnostic.
The transesophageal echocardiogram (TEE) clearly ruled out these causes
of shock and established the diagnosis of provokable hypertrophic obstruc-
tive cardiomyopathy (HOCM) with systolic anterior motion of the mitral valve
(SAM), increased left ventricular outflow tract velocity and mitral regurgita-
tion. None of the patients had asymmetric septal hypertrophy or positive
family history for HOCM and only one had a history of hypertension.
During the echo study, vasopressors were discontinued and serially IV
fluid, IV beta blocker followed by IV alpha constrictors were used stepwise
until the SAM and outflow tract obstruction resolved. The systolic blood pres-
sure (SBP), pulse (P) were recorded and Cardiac Output (CO) and Index (CI)
were noted with a Swan-Ganz catheter before and after the therapeutic in-
tervention and TEE:
We conclude that TEE is a valuable tool in patients with shock to establish
the cause of hypotension of undetermined etiology. Elucidating the patho-
physiology of severe hypotension by TEE can profoundly affect the man-
agement of these patients by correctly redirecting therapy. In patients with
severe hypotension who do not respond to vasopressors the diagnosis of
provokable HOCM should be considered and a TEE performed. The TEE is
valuable not only to diagnose this unusual condition but also to assist in
titrating therapy.
L-NMMA produced a significant increase in vascular resistance at rest,
after ACH, and after 3 and 5 minute periods of ischemia and hyperemia, but
did not affect endothelium-independent dilation with SNP Pts with greater
inhibition of ACH-induced dilation with L-NMMA also had a greater inhibition
of reactive hyperemia with L-NMMA (r = 0.47, P < 0.001).
Conclusions: 1) NO release contributes to microvascular vasodilation in
response to ischemia, and 2) endothelial dysfunction resulting in reduced
release of NO in response to ACH correlates with diminished vasodilatory
response to reactive hyperemia. These findings suggest that the contribu-
tion of NO to vasodilation in response to metabolic stress is attenuated in
pts with endothelial dysfunction and imply that endothelial dysfunction in
the coronary vasculature may, by limiting vasodilation during stress, also ac-
centuate myocardial ischemia.
out coronary artery disease. Endothelium-dependent and independent dila-
tion, before and after L-NMMA, was measured in the femoral circulation with
intra-arterial acetylcholine (ACH) and sodium nitroprusside (SNP), respec-
tively. Three and 5 minutes periods of ischemia were produced by cuff infla-
tion over the thigh and peak hyperemic responses were measured. Femoral
vascular resistance was derived from continuous Doppler flow velocity and
blood pressure measurements.
Results:
%lncrease in Vascular Resistance with L-NMMA
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